Bharat Parenterals

₹1,917As of Sun 8 Nov 2026, 12:00 UTC

NSE:BPLPHARMA—

Country India

PE (Fwd) —

TSR 10Y CAGR —

Div yield 0.05%

ROE —

Pharmaceutical Preparations

Beta (5Y) 0.65

PE TTM —

TSR TTM —

Mkt cap ₹13.76B

ROIC —

SE Grade™

—

Value

—

Quality

Moat

—

1Y Price

Reference

₹2,093

—

9.18%

—

FY23

FY24

FY25

FY26

Earnings per share₹

27.21

24.94

(19.26)

(11.88)

(26.67%)

(8.37%)

(177.26%)

38.33%

Revenue₹B

2.193

2.612

3.404

3.454

3.28%

19.11%

30.31%

1.48%

TTM

FYE 31 Mar INR

FY2017

FY2018

FY2019

FY2020

FY2021

FY2022

FY2023

FY2024

FY2025

FY2026

FY2027E

Trend

10Y

Peers

3.454

Revenue₹B

—

2.123

2.193

2.612

3.404

3.454

3.713

12.94%

1.48

Revenue growth%

—

3.28

19.11

30.31

1.48

7.49

11.20

—

42.95

Gross margin%

—

35.04

36.45

38.23

40.16

42.95

43.00

38.23

(5.32)

Operating margin%

—

11.54

9.04

6.99

(9.03)

(5.32)

(5.40)

6.99

(2.37)

Net margin%

—

10.03

7.17

5.56

(3.71)

(2.37)

(2.46)

5.56

—

P/E ratio (avg)x

—

EV/EBITx

—

FCF yield (avg)%

—

FCF margin%

—

FCF / Net incomex

—

ROIC%

—

Return on equity%

—

Return on assets%

—

(11.88)

EPS₹

—

37.11

27.21

24.94

(19.26)

(11.88)

(13.25)

(18.03%)

—

38.33

EPS growth%

—

(26.67)

(8.37)

(177.26)

38.33

(11.56)

(17.52)

—

Bookvalue per sh₹

—

FCF per share₹

—

1.00

Dividend per sh₹

—

0.75

1.00

1.05

10.06%

—

0.05

Div yield (avg)%

—

0.05

—

Payout ratio%

—

2.76

4.01

—

2.76

—

6.892

Shares (diluted)M

—

5.740

5.775

5.822

6.554

6.892

◌6.892

4.68%

(5.16)

Buyback yield%

—

(0.60)

(0.82)

(12.58)

(5.16)

◌—

(2.99)

—

D/E ratiox

—

13.21

Enterprise value₹B

—

13.21

—

LT debt₹M

—

Peers (US$136.0M)

Cap (US$)

Fermenta Biotech…

136.5M

25.81x

Sudarshan Pharma…

86.44M

26.89x

Trident Lifeline…

52.57M

21.04x

MPH Health Care AG

137.0M

2.520x

Capital

TTM

10Y

Leveragex

—

EBIT/Intx

(1.603)

5.743

Own earn%

—

Sh yield%

(5.10)

(2.99)

Owners

Insiders/Inst%

34.12

2.12

Short interest%

—

SBC / revenue%

—

Record

10Y

Profitable years

3/5

Revenue growth years

4/4

EPS growth years

1/4

Dividend streakyrs

Op margin range%

−9–12

$1 testx

—

Incr. ROIC%

—

Bharat Parenterals Limited engages in the research, development, manufacturing, marketing, sourcing, and distribution of pharmaceutical products in India and internationally.

Growth vs revenue

Latest

Trend

4Y CAGR

Rel growth

Revenue

₹3.454B

12.94%

1.00×

Cost of revenue

₹1.971B

9.33%

0.88×

Operating expenses

₹1.668B

35.20%

2.05×

Revenue by region

No breakdown available

Reinvestment returns

No breakdown available